Hello Everyone, Cardiex - One of the most undervalued stock on...

Hello Everyone,

Cardiex - One of the most undervalued stock on ASX, disrupting a 100 years old health sector.

Just thought to share some key highlights from company website and selective slides from November 2020 presentation.

• Gold standard FDA-cleared device for the measurement of central blood pressure and cardiovascular risk parameters (Standard FDA “predicate device”)
• Its currently used in 6 continents, 34 countries, 4000 plus installations
• FDA and CFDA Approved
• 16 New Trademarks
• Already obtained US reimbursement CPT Code
• All “Top 20 Hospitals” use SphygmoCor® technology to measure central blood pressure (cBP)
• 8 out of Top 10 Pharma companies have used SphygmoCor® technology in their clinical trials
• Over 11,000 patients have been tested with SphygmoCor® technology in pharmaceutical trials
• ‬Deep into the US telehealth sector worked with the biggest players such as Anthem (NSYE: ANTM)
• Showing leadership in the exciting and massive world of future health care‬
• Making strides in the US and now in China
• Current IP and technology focused on cardiovascular health
• Significant trademarks in consumer and wearable sectors
• Future applications in “Quantified Athlete”, remote patient monitoring, and broad health categories
• Proprietary IP & technology in cardiac load, athletic capacity, arterial stiffness, arterial age, and other consumer health diagnostic parameters
• Expanding licensing and co-development opportunities in broad medical and consumer health segments
• Over 1400 published peer-reviewed studies
• 13 USA patents covering significant applications in cardiovascular health and consumer wearables

2021 is one of the key year for the Company (Timelines or potential news flow)


Multiple new products and revenue streams for 2021

Clear strategy to drive revenue from different streams and targets



Market Comparable


In my opinion, its just a matter of time and we all be rewarded for our patient.

All in my opinion and research. Good luck to all and please do your own research.